Airs Sunday, July 28 at 6 p.m. The Food and Drug Administration, the oldest comprehensive consumer protection agency in the U.S. federal government, is charged with protecting the public health. Under this mandate, it regulates drugs and medical devices for their safety and effectiveness. But is it a failing mandate? It’s long been argued that the FDA’s long and costly approval processes stifle innovation and keep life-changing treatments from the market. But the question remains: when it comes to public health, is it ever okay to sacrifice safety for speed?
Arguing for the motion are Dr. Scott Gottlieb, Resident Fellow at the American Enterprise Institute and Peter Huber, Senior Fellow at the Manhattan Institute and Author. Arguing against the motion are Dr. Jerry Avorn, Professor of Medicine at Harvard Medical School and Dr. David Challoner, VP for Health Affairs Emeritus at the University of Florida.